GIP gastric inhibitory polypeptide
Selected indexed studies
- Changes in Gastric Inhibitory Polypeptide (GIP) After Roux-en-Y Gastric Bypass in Obese Patients: a Meta-analysis. (Obes Surg, 2022) [PMID:35597875]
- Gastric inhibitory polypeptide. (Clin Gastroenterol, 1980) [PMID:6107191]
- The biology of incretin hormones. (Cell Metab, 2006) [PMID:16517403]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Investigational and emerging gastric inhibitory polypeptide (GIP) receptor-based therapies for the treatment of obesity. (2024) pubmed
- Changes in Gastric Inhibitory Polypeptide (GIP) After Roux-en-Y Gastric Bypass in Obese Patients: a Meta-analysis. (2022) pubmed
- Gastric inhibitory polypeptide. (1980) pubmed
- The biology of incretin hormones. (2006) pubmed
- Blockade of gastric inhibitory polypeptide (GIP) action as a novel means of countering insulin resistance in the treatment of obesity-diabetes. (2020) pubmed
- Beyond the pancreas: contrasting cardiometabolic actions of GIP and GLP1. (2023) pubmed
- [Gastric inhibitory polypeptide (GIP) and GIP receptor (GIPR)]. (1996) pubmed
- Glucose-dependent insulinotropic polypeptide (Gastric Inhibitory Polypeptide; GIP). (2009) pubmed
- Glucose-Dependent Insulinotropic Polypeptide in Incretin Physiology: Role in Health and Disease. (2025) pubmed
- Gastric inhibitory polypeptide (GIP). (1978) pubmed